Diagnostics
InnotiveDx gets £1m grant to advance UTI diagnostics system
November 27, 2025Research and Development Diagnostics, InnotiveDx, Urology
InnotiveDx has announced that it has received a £1m grant from Pathways to Antimicrobial Clinical Efficacy (PACE) to advance the …
University of Birmingham scientists develop new MRI contrast agent
November 12, 2025Research and Development Diagnostics, MRI, University of Birmingham, medical imaging
Researchers at the University of Birmingham, UK, have developed a new class of magnetic resonance imaging (MRI) contrast agents that …
KIFFIK Biomedical expands leadership team with two executive appointments
August 14, 2025Research and Development Chief Investment Officer, Corporate, Diagnostics, KIFFIK Biomedical, chief scientific officer
KIFFIK Biomedical has strengthened its leadership team with the appointments of Rene Veloso as chief investment officer and Reginald Swift …
Inbiome’s rapid diagnostic platform approved for EU use, cuts infection identification time to just five hours
April 11, 2025Research and Development Diagnostics, EU, Inbiome
Dutch diagnostics firm Inbiome has received In Vitro Diagnostic Regulation (IVDR) certification from the EU for its Molecular Culture ID …
NICE recommends digital tech for ADHD diagnosis in children and young people
July 16, 2024Medical Communications ADHD, Diagnostics, NICE
The National Institute for Health and Care Excellence (NICE) has announced that its diagnostics advisory committee has recommended the QbTest …
Freenome raises $254m funding for early cancer detection platform
February 16, 2024Research and Development Diagnostics, Freenome, Oncology, cancer detection, funding
Freenome has announced that it has raised $254m from new and existing investors, intended to be used for the advancement …
Tempus receives FDA Premarket Approval for in vitro diagnostic scan
May 3, 2023Medical Communications Diagnostics, FDA, Oncology, Tempus, in vitro
US-based artificial intelligence (AI) and precision medicine company Tempus has announced that the US Food and Drug Administration (FDA) has …
Roche acquire GenMark in $1.8 billion deal
March 15, 2021Sales and Marketing Diagnostics, GenMark, Roche
Pharmaceutical giant Roche have bought GenMark Diagnostics in a deal worth $1.8 billion, expanding their infectious disease testing for illnesses …
Hospitals in Oxfordshire to test for susceptibility to dangers of chemotherapy
July 1, 2019Manufacturing and Production Cancer, Diagnostics, NHS, UK, breast, colon, oesophogus, pharma
Hospitals in Oxfordshire have introduced a genetic test which helps doctors predict the dangerous side effects of chemotherapy. In …
Manchester emerges as genomics research hub
May 29, 2019Research and Development Diagnostics, Manchester, UK, genomics, pharma
Manchester, UK is emerging as a major hub for genomics research, according to a new firm set up in collaboration …
Scottish biotech secures initial orders for HIV diagnosis kit from Indonesia, Moldova and Papua New Guinea
March 7, 2019Business Services, Medical Communications, Research and Development, Sales and Marketing Diagnostics, HIV, Indonesia, Moldova, Scotland, developing coutnries
A small biotech based in Clackmannanshire, Scotland expects to turnover an additional £20 million from sales of its HIV diagnostics …
Top Ten most popular articles on Pharmafile.com this week!
December 7, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Cancer, Diagnostics, Sanofi, Takeda, brexit
Takeda’s acquisition of Shire finally got the go-ahead this week as 88% of shareholders voted in favour of French CEO …
Lilly and Roche team up on new Alzheimer’s diagnostic test
January 28, 2016Research and Development Alzheimer's disease, Diagnostics, Roche, dementia, lilly
Eli Lilly has partnered with Roche Diagnostics to advance its development of a cerebrospinal fluid test for amyloid-beta 1-42, which …
Merck and Biocartis partner on new biomarker test for colorectal cancer
January 7, 2016Research and Development BRAF mutations, Diagnostics, Erbitux, Merck, RAS metations, diagnostic tests, metastic colorectal cancer
Merck has signed a collaboration agreement with diagnostics company Biocartis for the development and commercialisation of a new test for …
Birmingham opens BioHub for life science start-ups
August 18, 2015Manufacturing and Production Birmingham, Diagnostics, hubs, life sciences, research hubs, start-ups
A £7 million biomedical laboratory has opened in Birmingham to attract life-science researchers and start-ups. The BioHub is a new …
Latest content
FibroFind appoints Lee Borthwick as CEO
